Connexin 43 expression in irradiated human neck skin: a prospective case-control study
- PMID: 40115061
- PMCID: PMC11921269
- DOI: 10.21037/atm-24-158
Connexin 43 expression in irradiated human neck skin: a prospective case-control study
Abstract
Background: Overexpression of connexin 43 (Cx43) is seen in chronic cutaneous wounds of humans, and downregulation of Cx43 expedites healing. Human epithelia that have received radiotherapy can also suffer from chronic wounds. Since increased expression of Cx43 was observed in murine skin following irradiation, we sought to confirm this in irradiated human neck skin because Cx43 inhibition may be a novel treatment of wounds in such tissue.
Methods: We prospectively recruited adult patients who underwent elective neck surgery between November 2017 and March 2018 in the Otorhinolaryngology Department of a tertiary hospital in Singapore. A sample size of five patients with prior radiotherapy to 25 controls without radiotherapy was planned a priori. Immunohistochemical staining of Cx43 was performed in the neck skin obtained from the patients and quantified under confocal microscopy. The association between demographic factors, comorbidities of the patients, and Cx43 expression was explored. Wound healing was assessed between 7 to 14 days postoperatively.
Results: Five patients received radiotherapy 9 months to 27 years before surgery. The expression of Cx43 was 94.2 vs. 146.4 pixel-area/nucleus in the epidermis with or without radiotherapy, respectively (P=0.39). The demographics and co-morbidities of the patients with or without radiotherapy were similar except for relative anemia in the patients who had radiotherapy (hemoglobin of 12.15 vs. 14.10 g/dL, P=0.02), but hemoglobin was not correlated with Cx43 expression (P=0.93). All skin incisions healed without dehiscence.
Conclusions: Previous radiotherapy may not alter Cx43 expression in human neck skin. Whether the same is true for chronic radiation-induced wounds or acute radiation-induced dermatitis should be investigated.
Keywords: Connexin 43 (Cx43); human skin; neck; overexpression; radiation.
Copyright © 2025 AME Publishing Company. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-24-158/coif). H.L. reports that this work was supported by the National Medical Research Council of Singapore (research grant for Master of Clinical Investigation, National University of Singapore). The funding agency did not participate in the study in any other way. D.L.B. is the founding scientist of CoDa Therapeutics, a company that produces anti-sense oligonucleotide against connexin 43, but he and his laboratory members were blinded to the radiation status of the samples in this study. The other authors have no conflicts of interest to declare.
Figures



References
LinkOut - more resources
Full Text Sources